National Institute for Health and Care Excellence. (2022) Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. London: National Institute for Health and Care Excellence. NICE guideline [NG215].
| Preview | Title | Contact |
|---|---|---|
|
PDF (Medicines associated with dependence or withdrawal symptoms)
- Published Version
244kB |
External website: https://www.nice.org.uk/guidance/NG215
This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z‑drugs and antidepressants in primary and secondary care.
This guideline includes recommendations on:
- supporting people taking a dependence-forming medicine or antidepressant
- making decisions about prescribing and taking a medicine
- starting a medicine, including information and support, management planning, prescribing strategies and working with other healthcare professionals
- reviewing a medicine
- making shared decisions about withdrawing medicines
- dose reduction, managing withdrawal symptoms and interventions to support withdrawal
B Substances > New (novel) psychoactive substances > Benzodiazepines
B Substances > New (novel) psychoactive substances > Other novel substances > Gabapentinoids GABA (Pregabalin / Gabapentin)
E Concepts in biomedical areas > Medical substance > Over the counter drug (medicine / medication)
E Concepts in biomedical areas > Medical substance > Prescription drug (medicine / medication)
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug withdrawal
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
VA Geographic area > International
Repository Staff Only: item control page